ArticleEuropean journal of heart failure2022

Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.

John W Ostrominski et al.PubMed ↗Publisher ↗

No numbers read from the abstract.